Digging deeper into the field of the small cell lung cancer tumor marker progrp: A method for differentiation of its isoforms

Journal of Proteome Research

Volumn 12, Issue 1, 2013, Pages 412-420

  Torsetnes, Silje Bøen ^a   Nordlund, Marianne Sparby ^b   Paus, Elisabeth ^b   Halvorsen, Trine Grønhaug ^a   Reubsaet, Léon ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Biomarkers; Bottom up proteomics; Isoforms; LC MS MS; Method validation; ProGRP; Signature peptide; Small cell lung cancer (SCLC); Targeted proteomics

Indexed keywords

PROGASTRIN RELEASING PEPTIDE; PROGASTRIN RELEASING PEPTIDE 2; PROGASTRIN RELEASING PEPTIDE 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; CELL DIFFERENTIATION; DISEASE MARKER; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LUNG SMALL CELL CANCER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; SEPARATION TECHNIQUE; VALIDATION PROCESS;

CHROMATOGRAPHY, LIQUID; HUMANS; LUNG NEOPLASMS; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84874081055     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300751j     Document Type: Article

References (28)

1. Sturgeon, C.; Hill, R.; Hortin, G. L.; Thompson, D. Taking a new biomarker into routine use-a perspective from the routine clinical biochemistry laboratory. Proteomics Clin. Appl. 2010, 4 (12), 892-903.
2. Martinkova, J.; Gadher, S. J.; Hajduch, M.; Kovarova, H. Challenges in cancer research and multifaceted approaches for cancer biomarker quest. FEBS Lett. 2009, 583 (11), 1772-84.
3. Horn, L.; Pao, W.; Johnson, H., D., Harrison's Online-Part 7. Oncology and Hematology. In Harrison's Principles of Internal Medicine, 18th ed.; Longo, L. D., Kasper, L., D., Jameson, L. J., Anthony, S., F., Hauser, L., S., Loscalzo, J., Eds.; The McGraw-Hill Companies: AccessMedicine, 2011.
4. Planchard, D.; Le Pe?choux, C. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment. Eur. J. Cancer 2011, 47 (Supplement 3, (0)), S272-83.
5. Cho, J.-Y.; Sung, H.-J. Proteomic approaches in lung cancer biomarker development. Expert Rev. Proteomics 2009, 6 (1), 27-42.
6. Abrams, J.; Doyle, L. A.; Aisner, J. Staging, prognostic factors, and special considerations in small cell lung cancer. Semin. Oncol. 1988, 15 (3), 261-77.
7. Molina, R.; Auge?, J.; Bosch, X.; Escudero, J.; Vin?olas, N.; Marrades, R.; Ramírez, J.; Carcereny, E.; Filella, X. Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology. Tumor Biol. 2009, 30, 121-129.
8. Shibayama, T.; Ueoka, H.; Nishii, K.; Kiura, K.; Tabata, M.; Miyatake, K.; Kitajima, T.; Harada, M. Complementary roles of progastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer 2001, 32, 61-69.
9. Wood, S. M.; Wood, J. R.; Ghatei, M. A.; Lee, Y. C.; O'Shaughnessy, D.; Bloom, S. R. Bombesin, Somatostatin and Neurotensin-Like Immunoreactivity in Bronchial Carsinoma. J. Clin. Endocrinol. Metab. 1981, 53 (6), 1310-1312.
10. Moody, T. W.; Pert, C. B.; Gazdar, A. F.; Carney, D. N.; Minna, J. D. High Levels of Intracellular Bombesin Characterize Human Small-Cell Lung Carcinoma. Science 1981, 214 (4526), 1246-1248.
11. Spindel, E. R.; Chin, W. W.; Price, J.; Rees, L. H.; Besser, G. M.; Habener, J. F. Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc. Natl. Acad. Sci. U.S.A. 1984, 81 (18), 5699-5703.
12. Palmblad, M.; Tiss, A.; Cramer, R. Mass spectrometry in clinical proteomics-from the present to the future. Proteomics Clin. Appl. 2009, 3 (1), 6-17.
13. van den Ouweland, J. M.; Kema, I. P. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2012, 883-884, 18-32.
14. Lund, H.; Torsetnes, B. T.; Paus, E.; Nustad, K.; Reubsaet, L.; Halvorsen, T. G. Exploring the complementary selectivity of immunocapture and MS detection for the differention between hCG isoforms in clinicaly relevant samples. J. Proteome Res. 2009, 8 (11), 5241-5252.
15. Kim, K.; Kim, Y. Preparing multiple-reaction monitoring for quantitative clinical proteomics. Expert Rev. Proteomics 2009, 6 (3), 225-229.
16. Bantscheff, M.; Schirle, M.; Sweetman, G.; Rick, J.; Kuster, B. Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 2007, 389 (4), 1017-31.
17. Winther, B.; Nordlund, M.; Paus, E.; Reubsaet, L.; Halvorsen, T. G. Immuno-capture as ultimate sample cleanup in LC-MS/MS determination of the early stage biomarker ProGRP. J. Sep. Sci. 2009, 32 (17), 2937-43.
18. Winther, B.; Moi, P.; Paus, E.; Reubsaet, J. L. Targeted determination of the early stage SCLC specific biomarker pro-gastrinreleasing peptide (ProGRP) at clinical concentration levels in human serum using LC-MS. J. Sep. Sci. 2007, 30 (16), 2638-46.
19. Nordlund, M. S.; Warren, D. J.; Laerdahl, J. K.; Paus, E. Studies on Multiple Forms of proGRP in Serum from Small Cell Lung Cancer Patients. Tumor Biol. 2009, 30 (5-6), 265-275.
20. Nordlund, M. S.; Fermer, C.; Nilsson, O.; Warren, D. J.; Paus, E. Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP. Tumor Biol. 2007, 28 (2), 100-110.
21. Paus, E.; Nustad, K. Immunoradiometric assay for alpha gammaand gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin. Chem. 1989, 35 (10), 2034-2038.
22. Altschul, S. F.; Madden, T. L.; Scha?ffer, A. A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25 (17), 3389-3402.
23. ICH: Q2 (R1): Validation of analytical procedures: Text and methodology; ICH Secretariat: London, 1995.
24. Winther, B.; Reubsaet, J. L. Determination of the small cell lung cancer associated biomarker pro-gastrin-releasing peptide (ProGRP) using LC-MS. J. Sep. Sci. 2007, 30 (2), 234-40.
25. Spindel, E. R.; Zilberberg, M. D.; Chin, W. W. Analysis of the Gene and Multiple Messenger Ribonucleic Acids (mRNAs) Encoding Human Gastrin-Releasing Peptide: Alternate RNA Splicing Occurs in Neural and Endocrine Tissue. Mol. Endocrinol. 1987, 1 (3), 224-232.
26. Uchida, K.; Kojima, A.; Morokawa, N.; Tanabe, O.; Anzai, C.; Kawakami, M.; Eto, Y.; Yoshimura, K. Expression of progastrinreleasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer. J. Cancer Res. Clin. Oncol. 2002, 128 (12), 633-640.
27. Nordlund, M. S.; Bjerner, J.; Warren, D. J.; Nustad, K.; Paus, E. Progastrin-releasing peptide: Stability in plasma/serum and upper reference limit. Tumor Biol. 2008, 29 (3), 204-10.
28. Aoyagi, K.; Miyake, Y.; Urakami, K.; Kashiwakuma, T.; Hasegawa, A.; Kodama, T.; Yamaguchi, K. Enzyme-Immunoassay of Immunoreactive Progastrin-Releasing Peptide(31-98) as Tumor-Marker for Small-Cell Lung-Carcinoma-Development and Evaluation. Clin. Chem. 1995, 41 (4), 537-543.